Home LiteratureArticle Details
PMID: 7881744 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine.

British journal of pharmacology ·Vol. 114 ·No. 2 ·1995-01-00 ·Pages 454-60

Benwell ME, Balfour DJ, Birrell CE

Abstract

1. The effects of constant nicotine infusions (0.25, 1.0 and 4.0 mg kg-1 day-1) on extracellular dopamine levels in the nucleus accumbens (NAc) and on locomotor activity have been compared with the changes evoked by repeated daily injections (0.4 mg kg-1 day-1 for 5 days) of the drug. 2. The extracellular dopamine concentration in the NAc was significantly increased (P < 0.05) following a challenge dose of nicotine (0.4 mg kg-1, s.c.) in animals which had been pretreated with daily injections of the drug. This effect was accompanied by an enhanced locomotor response to nicotine. 3. The stimulant effects of nicotine on mesolimbic dopamine secretion and on locomotor activity were significantly inhibited (P < 0.01) by the prior administration of mecamylamine (2.0 mg kg-1, s.c.) but not by hexamethonium (2.0 mg kg-1, s.c.). 4. The constant infusion of nicotine at a rate of 1 and 4 but not 0.25 mg kg-1 day-1 abolished the sensitized dopamine response in the NAc to an injection of nicotine in animals pretreated with the drug. The locomotor responses to nicotine in the nicotine-pretreated rats were significantly attenuated by the infusion of nicotine at all 3 doses, although the nicotine induced locomotor activity, in the rats infused with 0.25 mg kg-1 day-1 was also significantly (P < 0.05) higher than that observed in the rats treated acutely with nicotine. 5. Significantly (P<0.01) enhanced mesolimbic dopamine responses, to a challenge injection of nicotine(0.4 mg kg-1, s.c.), were observed 2 and 7 days after termination of the infusion of nicotine (4 mg kg-1 day-1 for 14 days); locomotor responses were enhanced (P<0.01) 1, 2 and 7 days after termination of the infusion.6. The results suggest that sensitized mesolimbic dopamine responses to nicotine occur as a result of stimulation of centrally located nicotinic receptors but that these receptors may be desensitized during periods of chronic exposure to nicotine at doses which may be relevant to smoking.

MeSH Terms
3,4-Dihydroxyphenylacetic Acid/metabolism Animals Dopamine/metabolism Extracellular Space/drug effects,metabolism Hexamethonium/pharmacology Homovanillic Acid/metabolism Infusion Pumps, Implantable Limbic System/drug effects,metabolism Male Mecamylamine/pharmacology Microdialysis Motor Activity/drug effects Nicotine/administration & dosage,blood,pharmacology Rats Rats, Sprague-Dawley
Chemicals
3,4-Dihydroxyphenylacetic Acid Hexamethonium Mecamylamine Nicotine Dopamine Homovanillic Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Benwell M E
Department of Pharmacology and Clinical Pharmacology, University of Dundee Medical School, Ninewells Hospital.
Balfour D J
Birrell C E
References (25)
25 references, click to expand
  1. Cardiovascular and subjective effects of smoking before and after 24 h of abstinence from cigarettes.
    Psychopharmacology (Berl). 1987;92(1):118-21 PMID: 3110822
  2. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.
    Eur J Pharmacol. 1986 Dec 16;132(2-3):337-8 PMID: 3816984
  3. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    J Neurochem. 1988 Jan;50(1):243-7 PMID: 3335842
  4. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8 PMID: 2899326
  5. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.
    Brain Res. 1988 Jul 12;455(2):332-45 PMID: 2900058
  6. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
    J Pharmacol Exp Ther. 1988 Aug;246(2):701-8 PMID: 3136244
  7. Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain.
    Clin Neuropharmacol. 1987 Aug;10(4):376-83 PMID: 3503681
  8. Effects of chronic nicotine pretreatment on (+)-amphetamine and nicotine-induced synthesis and release of [3H]dopamine from [3H]tyrosine in rat nucleus accumbens.
    J Pharm Pharmacol. 1989 Jan;41(1):66-8 PMID: 2565971
  9. Aversive environmental stimuli as a factor in the psychostimulant response to nicotine.
    Pharmacol Biochem Behav. 1989 Apr;32(4):857-60 PMID: 2798534
  10. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens.
    Eur J Pharmacol. 1989 Sep 22;168(3):363-8 PMID: 2479574
  11. Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat.
    Prog Brain Res. 1989;79:257-65 PMID: 2587746
  12. Locomotor activity in rats after administration of nicotinic agonists intracerebrally.
    Br J Pharmacol. 1990 Feb;99(2):273-8 PMID: 2328395
  13. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.
    Psychopharmacology (Berl). 1992;107(2-3):285-9 PMID: 1615127
  14. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity.
    Br J Pharmacol. 1992 Apr;105(4):849-56 PMID: 1504716
  15. Chronic and acute tolerance to subjective effects of nicotine.
    Pharmacol Biochem Behav. 1993 Jun;45(2):375-81 PMID: 8327544
  16. Higher levels of nicotine in arterial than in venous blood after cigarette smoking.
    Drug Alcohol Depend. 1993 Jun;33(1):23-9 PMID: 8370337
  17. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
    Synapse. 1994 Jan;16(1):36-44 PMID: 8134899
  18. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.
    Psychopharmacology (Berl). 1993;112(4):467-74 PMID: 7871059
  19. Cigarette smoking: a dependence on high-nicotine boli.
    Drug Metab Rev. 1978;8(1):29-57 PMID: 31270
  20. Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat.
    Pharmacol Biochem Behav. 1982 Sep;17(3):579-81 PMID: 7146054
  21. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs.
    J Neurochem. 1985 Aug;45(2):427-33 PMID: 4009168
  22. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.
    Brain Res. 1985 Dec 2;348(2):355-8 PMID: 4075093
  23. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
    J Pharmacol Exp Ther. 1985 Dec;235(3):619-28 PMID: 4078726
  24. Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke.
    J Neural Transm. 1986;67(1-2):15-29 PMID: 2878061
  25. A psychomotor stimulant theory of addiction.
    Psychol Rev. 1987 Oct;94(4):469-92 PMID: 3317472
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1995-01-00
Pages
454-60
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1510263
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]